Camryn Prejean, PA
Surgical · Baton Rouge, LANPI 1366119919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $486 and has fallen 50.3% since, to $241 in 2025.
Across 61 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$174
- Pacira Pharmaceuticals Incorporated$139
- Lilly USA, LLC$134
- Alcresta Therapeutics, Inc.$94
- Johnson & Johnson$92
- BD$80
- plus $562 from 18 others
What the payments were for
- Food & beverage$1,26199%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $174 |
| Pacira Pharmaceuticals Incorporated | 8 | $139 |
| Lilly USA, LLC | 7 | $134 |
| Alcresta Therapeutics, Inc. | 4 | $94 |
| Johnson & Johnson | 5 | $92 |
| BD | 4 | $80 |
| Kowa Pharmaceuticals America, Inc. | 5 | $80 |
| Davol Inc. | 2 | $60 |
| Intuitive Surgical | 2 | $45 |
| Dilon Technologies, Inc. | 1 | $39 |
| Aroa Biosurgery Incorporated | 1 | $38 |
| Solventum Corporation | 1 | $37 |
| Edwards Lifesciences | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Biocon Biologics Inc | 1 | $26 |
| Baxter Healthcare | 1 | $24 |
| Histosonics, Inc. | 1 | $23 |
| La Jolla Pharmaceutical Company | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Vertex | 1 | $16 |
| Celltrion USA Inc. | 1 | $15 |
How this compares
$1,276 in reported general payments places this provider in the 70th percentile of 130 surgical providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 73 | $204 |
| Tramadol Hcl | 120 | $203 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $67 |
Paid to pharmacies, not to this prescriber.
Other surgical in Baton Rouge
- Brandie HenryBaton Rouge$6K
- Jonathan FletcherBaton Rouge$5K
- Amanda KwanBaton Rouge$4K
- Alicia VickBaton Rouge$3K
- Valarie ComeauBaton Rouge$3K
- Justin AllenBaton Rouge$3K
- Kiranbhai PatelBaton Rouge$3K
- Natalie DupuyBaton Rouge$3K
- Camille WilliamsBaton Rouge$2K
- Kristene OlindeBaton Rouge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.